Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?

por Taskinen, Marja-Riitta, Borén, Jan
Publicado en Curr Atheroscler Rep (2016)

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

por Taskinen, Marja-Riitta, Packard, Chris J., Borén, Jan
Publicado en Curr Atheroscler Rep (2019)

Dietary Fructose and the Metabolic Syndrome

por Taskinen, Marja-Riitta, Packard, Chris J, Borén, Jan
Publicado en Nutrients (2019)

Causes and Consequences of Hypertriglyceridemia

por Packard, Chris J., Boren, Jan, Taskinen, Marja-Riitta
Publicado en Front Endocrinol (Lausanne) (2020)

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

por Borén, Jan, Packard, Chris J., Taskinen, Marja-Riitta
Publicado en Front Endocrinol (Lausanne) (2020)

Effect of HDL composition and particle size on the resistance of HDL to the oxidation

por Shuhei, Nakanishi, Söderlund, Sanni, Jauhiainen, Matti, Taskinen, Marja-Riitta
Publicado 2010

Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

por Adiels, Martin, Mardinoglu, Adil, Taskinen, Marja-Riitta, Borén, Jan
Publicado en Front Physiol (2015)

ApoE Polymorphism Is Associated With C-Reactive Protein in Low-HDL Family Members and in Normolipidemic Subjects

por Kahri, Juhani, Soro-Paavonen, Aino, Ehnholm, Christian, Taskinen, Marja-Riitta
Publicado 2006

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

por Krengel, Annette, Hauth, Jan, Taskinen, Marja-Riitta, Adiels, Martin, Jirstrand, Mats
Publicado 2013

Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models

por Berglund, Martin, Adiels, Martin, Taskinen, Marja-Riitta, Borén, Jan, Wennberg, Bernt
Publicado en PLoS One (2015)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

por Forsblom, Carol, Hiukka, Anne, Leinonen, Eeva S., Sundvall, Jouko, Groop, Per-Henrik, Taskinen, Marja-Riitta
Publicado 2010

Quantifying triglyceride-rich lipoprotein atherogenicity, associations with inflammation, and implications for risk assessment using non-HDL cholesterol

por Björnson, Elias, Adiels, Martin, Gummesson, Anders, Taskinen, Marja-Riitta, Burgess, Stephen, Packard, Chris J, Borén, Jan
Publicado en J Am Coll Cardiol (2024)

Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single‐centre randomized contr...

por Matikainen, Niina, Söderlund, Sanni, Björnson, Elias, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Taskinen, Marja‐Riitta, Borén, Jan
Publicado en Diabetes Obes Metab (2018)

Lipoprotein(a) is Markedly More Atherogenic than LDL: An Apolipoprotein B-based Genetic Analysis

por Björnson, Elias, Adiels, Martin, Taskinen, Marja-Riitta, Burgess, Stephen, Chapman, M. John, Packard, Chris J, Borén, Jan
Publicado en J Am Coll Cardiol (2024)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Interven...

por Scott, Russell, O'Brien, Richard, Fulcher, Greg, Pardy, Chris, d'Emden, Michael, Tse, Dana, Taskinen, Marja-Riitta, Ehnholm, Christian, Keech, Anthony
Publicado 2009

High-resolution population-specific recombination rates and their effect on phasing and genotype imputation

por Hassan, Shabbeer, Surakka, Ida, Taskinen, Marja-Riitta, Salomaa, Veikko, Palotie, Aarno, Wessman, Maija, Tukiainen, Taru, Pirinen, Matti, Palta, Priit, Ripatti, Samuli
Publicado en Eur J Hum Genet (2020)

Variation in GYS1 Interacts with Exercise and Gender to Predict Cardiovascular Mortality

por Fredriksson, Jenny, Anevski, Dragi, Almgren, Peter, Sjögren, Marketa, Lyssenko, Valeriya, Carlson, Joyce, Isomaa, Bo, Taskinen, Marja-Riitta, Groop, Leif, Orho-Melander, Marju
Publicado 2007

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol

por Yetukuri, Laxman, Söderlund, Sanni, Koivuniemi, Artturi, Seppänen-Laakso, Tuulikki, Niemelä, Perttu S., Hyvönen, Marja, Taskinen, Marja-Riitta, Vattulainen, Ilpo, Jauhiainen, Matti, Orešič, Matej
Publicado 2010

Cardiac steatosis and left ventricular function in men with metabolic syndrome

por Nyman, Kristofer, Granér, Marit, Pentikäinen, Markku O, Lundbom, Jesper, Hakkarainen, Antti, Sirén, Reijo, Nieminen, Markku S, Taskinen, Marja-Riitta, Lundbom, Nina, Lauerma, Kirsi
Publicado 2013

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

por Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Publicado 2010